UCB reports success in phase 3 study of fenfluramine for CDD - PharmaTimes Positive trial results offer hope for those with ultra-rare epileptic disorder

#UCB #fenfluramine #CDD #ultrarareepilepticdisorder #ultrararediseases #CDKL5deficiencydisorder #developmentalandepilepticencephalopathy #DEE #earlyonsetepilepsy #neurodevelopmentaldelays #developmentalandepilepticencephalopathies #CDKL5gene
pharmatimes.com/news/ucb-rep...